This is Gilead's third acquisition this year alone. At this point, M&A is less about growth and more about survival for the ...

When broken down, the word "biotechnology" can be separated into two parts: bio, which means life, and technology, which is the application of scientific knowledge for useful purposes. Therefore, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Innovation Quarter is ...

Gilead Sciences has agreed to buy German clinical-stage biotechnology company Tubulis for up to $5 billion in a deal that ...

Returning for its fourth year, Bisnow’s International Life Sciences & Biotech Conference returns to San Diego in September 2026, bringing together global leaders across biotechnology, real estate, ...

The life sciences industry is experiencing transformative shifts driven by technological innovation and urgent global health needs. AAA Biotech, a leading provider of premium research reagents, is ...

Imagine the perfect drink — a cocktail, coffee, or kombucha, perhaps. Whatever the concoction, it came together iteratively — one taste test, one tweak at a time. In much the same way, mixing ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. PALO ALTO, Calif. — At an annual meeting usually focused on the industry’s future, ...

Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, ...

Tomorrow BioTech and The Super Crowd join forces to give biotech startups labs, crowdfunding, and capital to turn research into real-world solutions. By uniting BADASS Labs’ biotech infrastructure ...

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...